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Abstract 
In fibroblasts, the protein kinase C (PKC) activator phorbol 12-myristate (PMA) either inhibits or stimulates phospholipase 
C-mediated hydrolysis of phosphatidylethanolamine in the absence or presence of ethanol, respectively. Here, we demonstrate that the 
specific PKC inhibitor bisindolylmaleimide GF 109203X prevents only the inhibitory, but not the stimulatory, PMA effect. 
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Recent work in our laboratory revealed that in NIH 3T3 
fibroblasts, phosphatidylethanolamine (PtdEtn) can be hy- 
drolyzed by both phospholipase D (PLD) [1] and phospho- 
lipase C (PLC) [2] enzymes. Interestingly, the potent pro- 
tein kinase C (PKC) activator phorbol 12-myristate 13- 
acetate (PMA) alone either stimulates or inhibits PtdEtn 
hydrolysis by PLD [1] or PLC [2], respectively. However, 
in the presence of ethanol, PMA stimulates PLC-mediated 
PtdEtn hydrolysis [2]. Since PMA and ethanol have no 
effects on PLC-mediated PtdCho hydrolysis [3], it is possi- 
ble that fibroblasts possess a PtdEtn-specific PLC activity. 
The combined effects of PMA and ethanol on PLC- 
mediated PtdEtn hydrolysis occur after a relatively longer 
( = 20 min) lag period, which could mean that PLD-media- 
ted phospholipid hydrolysis is a necessary event for the 
stimulation of PLC by PMA. We have previously at- 
tempted to examine this possibility by using two non- 
specific inhibitors of PKC, 1-(5-isoquinolinylsulfonyl)-2- 
methylpiperazine and staurosporine [4,5]. However, even 
at very high concentrations these agents had only relatively 
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small inhibitory effects on PMA-induced PLD-mediated 
PtdEtn hydrolysis [2]. Thus, the issue of possible relation- 
ship between the effects of PMA on PLD and PLC activi- 
ties has remained unresolved. Clearly, selective and strong 
inhibition of PMA effect on either PLD- or PLC-mediated 
PtdEtn hydrolysis would help to clarify this issue. 
We have previously demonstrated that PKC-a is a 
likely mediator of the inhibitory PMA effect on PLC 
activity [2]. Since PMA relatively rapidly down-regulates 
this enzyme in NIH 3T3 fibroblasts [2], it is possible that 
this event alone is sufficient o promote the stimulatory 
effect of ethanol on PLC activity. If this were the case, a 
selective PKC inhibitor would be expected to be as effec- 
tive as PMA to enhance the stimulatory effect of ethanol 
on PLC activity. 
The bisindolylmaleimide GF 109203X has recently been 
established as a potent and specific inhibitor of PKC [6]. 
Here we used this inhibitor to assess the role of PKC- 
mediated protein phosphorylation in the mediation of vari- 
ous effects of PMA on PtdEtn hydrolysis. The most impor- 
tant finding is that GF 109203X failed to prevent the 
potentiating effect of PMA on ethanol-induced PLC activ- 
ity. 
For these studies, NIH 3T3 fibroblasts were cultured 
continuously in Dulbecco's modified Eagle's medium 
(DMEM) supplemented with 10% fetal calf serum, peni- 
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cillin and streptomycin (50 U /ml  and 50 /zg/ml, respec- 
tively), and glutamine (2 mM). Fibroblasts were seeded in 
150 mm dishes (Costar), and then incubated with [2- 
14C]ethanolamine (0.25 /zCi/ml) (Amersham) for 60 h. 
Confluent cultures were washed with fresh medium, and 
incubated in fresh DMEM for 3 h to reduce the amount of 
unincorporated [14C]ethanolamine [7]. Cells were har- 
vested by gentle scraping from the dish and counted 
hemocytometrically. At this step, 90-95% of cells were 
viable, determined by the Trypan blue dye exclusion assay. 
Aliquots (0.2 ml) of cell suspension (1.2. 106-1.5 • 106 
cells in 1 ml DMEM) were incubated (final volume 0.25 
ml) in polypropylene tubes at 37°C. The incubation medium 
contained 2 mM unlabeled ethanolamine to suppress phos- 
phorylation and/or re-esterification f newly formed 14C- 
labeled ethanolamine and ethanolamine phosphate as de- 
scribed earlier [1,2,7]; this protocol ensures that production 
of 14C-labeled ethanolamine and ethanolamine phosphate 
occurs only through PLD- and PLC-mediated mechanisms, 
respectively. Incubations were terminated and 14C-labeled 
water-soluble products of PtdEtn were separated on 
Dowex-50WH + resin as described elsewhere [7]. 
In a previous study [2], growing [14C]ethanolamine 
(Etn)-labeled cell populations were used for the study of 
effects of PMA and ethanol on PLC-mediated PtdEtn 
hydrolysis. These cells contained relatively high back- 
ground levels of [14C]ethanolamine phosphate (EtnP) 
(3500-5000 dpm/106 cells), and the inhibitory effects of 
PMA on EtnP formation varied between 20-60%. 
Presently, we used confluent cultures which contained 
significantly less background levels of [14C]EtnP (1200- 
1900 dpm/106 cells) and in which 100 nM PMA consis- 
tently (eight experiments were performed) inhibited the 
formation of [14C]EtnP by 65-79%. We also should em- 
phasize that in the present study we used only 75 mM 
ethanol which represents a physiologically relevant con- 
centration, although it does not elicit a maximal response 
on PLC activity [2]. 
As shown in Fig. 1, the large inhibitory effect of PMA 
(Sigma) on the formation of [14C]EtnP from [14C]PtdEtn 
was completely prevented by 0.2-0.5 /xM concentrations 
of GF 109203X (Calbiochem) when this inhibitor was 
added to cells 20 min before PMA. Interestingly, higher 
(2.5-75 /zM) concentrations of GF 109203X slightly, but 
consistently, enhanced the formation of [14C]EtnP in the 
presence of PMA. Evaluation of the significance and de- 
pendence of these stimulatory effects on the length of 
incubation time and concentration of PMA is presently 
underway in our laboratory. Ethanol (75 mM) alone en- 
hanced the formation of [laC]EtnP (Fig. 1) as previously 
described [2]. Importantly, even at the highest concentra- 
tion of inhibitor tested, GF 109203X failed to significantly 
modify the stimulatory effect of ethanol (Fig. 1). PMA 
(100 nM) enhanced the stimulatory effect of ethanol on the 
formation of [14C]EtnP about two-fold. However, addition 
of GF 109203X to fibroblasts 20 min before PMA failed to 
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Fig. 1. Effects of GF 109203X on PLC-mediated formation of[14C]EtnP 
in [14C]Etn-labeled fibroblasts. Attached NIH 3T3 fibroblasts were la- 
beled with [14C]ethanolamine for 60 h, followed by pretreatments of 
suspended fibroblasts with 0.1-75 /zM concentrations of GF 109203X 
for 20 min as appropriate. This incubation step was followed by treat- 
ments with GF 109203X for 2 h in the absence (O), or presence of100 
nM PMA (,t), 75 mM ethanol (11), or PMA plus ethanol (0). The 14C 
content of PtdEtn was 1.08.106-1.21 • 10 6 dpm/106 cells. Each point 
represents he mean+S.E.M, of six independent i cubations. Similar 
results were obtained in two other experiments, each performed in
triplicate. 
prevent he potentiating effect of PMA on ethanol-induced 
formation of [14C]EtnP. In fact, GF 109203X significantly 
increased the combined stimulatory effects of PMA and 
ethanol (Fig. 1); this may reflect suspension of the in- 
hibitory PMA action occurring by a different mechanism. 
Since we have not been able to exclude the possibility 
that PMA-induced PLD-mediated phospholipid hydrolysis 
is somehow linked to the stimulatory effect of PMA on 
PLC activity, we also determined the effects of GF 
109203X on the formation of [14C]Etn, a product of PLD 
action. As indicated in Fig. 2, GF 109203X strongly 
inhibited PMA-induced formation of [laC]Etn both in the 
absence and presence of 75 mM ethanol. In other experi- 
ments, GF 109203X was also found to potently inhibit 
PMA-induced PLD-mediated hydrolysis of phosphatidyl- 
choline (data not shown). These data clearly indicate that 
the potentiating effects of PMA on ethanol-induced PLC 
activity are independent of its effects on PLD activity. 
In summary, these data indicate that GF 109203X, a 
selective inhibitor of PKC, does not inhibit the potentiating 
effect of PMA on ethanol-induced PLC-mediated PtdEtn 
hydrolysis. This indicates that this effect of PMA is not 
mediated by a protein phosphorylation reaction. In con- 
trast, the ability of GF 109203X to diminish the inhibitory 
and stimulatory effects of PMA on PLC and PLD activi- 
ties, respectively, suggests that these effects of PMA in- 
volve protein phosphorylation. These data also demon- 
strate that regulation of PLD and PLC activities by PMA 
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Fig. 2. Effects of GF 109203X on PLD-mediated formation of [14C]Etn 
in [14C]Etn-labeled fibroblasts. Tl~te formation of [14C]Etn from the 
cellular pool of [ 14 C]PtdEtn was determined in the same experiments hat 
were described in legend to Fig. 1. Each point represents the mean _+ 
S.E.M. of six independent incubations. Determination of [14C]Etn in two 
additional experiments (each performed in triplicate) yielded similar 
results. 
occurs by independent mechanisms, and that the poten- 
tiating effect of PMA on ethanol-induced PLC activity is 
not simply due to the down-regulation f PKC-a. 
EtnP is known to accurnulate in most human cancer 
tissues [8-13]. Since increased formation of EtnP may 
represent a very early event in carcinogenesis [14], it is of 
interest to determine how the cellular level of EtnP is 
regulated. The findings that ethanol and PMA, which are 
known tumor promoters in several tissues, can exert stimu- 
latory effects on EtnP formation add additional weight to 
the importance of this issue. 
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